Warnke R A, Strauchen J A, Burke J S, Hoppe R T, Campbell B A, Dorfman R F
Cancer. 1982 Aug 15;50(4):690-5. doi: 10.1002/1097-0142(19820815)50:4<690::aid-cncr2820500412>3.0.co;2-l.
One hundred eighty-seven patients with confirmed diffuse non-Hodgkin's lymphoma were selected from a consecutive series of 391 patients who were evaluated and treated at Stanford University Medical Center. Lymphomas with any degree of nodularity and diffuse lymphomas of "well-differentiated" and "poorly differentiated" lymphocytic type were excluded from this study. Each of four observers identified cases of diffuse large-cell lymphoma from the 187 cases and further subdivided these cases into six morphologic types in accordance with criteria proposed by Strauchen et al. Initial intraobserver and interobserver agreement was relatively low but was greatly enhanced when the initial six morphologic types were grouped as either follicular center-cell or nonfollicular center-cell types. When individual observer results were pooled, statistically significant differences were seen between survival of patients in these two groups, with the patients in the nonfollicular differences were seen between survival of patients in these two groups, with the patients in the nonfollicular center-cell group having a worse prognosis (P = 0.04). This effect of morphologic type appeared to be independent of pathologic stage. Mitotic counts did not correlate with survival.
从斯坦福大学医学中心接受评估和治疗的391例连续病例中,选取了187例确诊为弥漫性非霍奇金淋巴瘤的患者。本研究排除了任何程度结节性的淋巴瘤以及“高分化”和“低分化”淋巴细胞型的弥漫性淋巴瘤。四位观察者分别从这187例病例中识别出弥漫性大细胞淋巴瘤病例,并根据斯特劳申等人提出的标准将这些病例进一步细分为六种形态学类型。最初观察者内部和观察者之间的一致性相对较低,但当最初的六种形态学类型归为滤泡中心细胞型或非滤泡中心细胞型时,一致性大大提高。当汇总个体观察者的结果时,发现这两组患者的生存率存在统计学上的显著差异,非滤泡中心细胞组患者的预后较差(P = 0.04)。形态学类型的这种影响似乎与病理分期无关。有丝分裂计数与生存率无关。